Gregory Karen J, Velagaleti Ranganadh, Thal David M, Brady Ryan M, Christopoulos Arthur, Conn P Jeffrey, Lapinsky David J
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University , Parkville, Victoria, Australia.
Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University , Pittsburgh, Pennsylvania, United States.
ACS Chem Biol. 2016 Jul 15;11(7):1870-9. doi: 10.1021/acschembio.6b00026. Epub 2016 May 4.
G protein-coupled receptors (GPCRs) represent the largest class of current drug targets. In particular, small-molecule allosteric modulators offer substantial potential for selectively "tuning" GPCR activity. However, there remains a critical need for experimental strategies that unambiguously determine direct allosteric ligand-GPCR interactions, to facilitate both chemical biology studies and rational structure-based drug design. We now report the development and use of first-in-class clickable allosteric photoprobes for a GPCR based on metabotropic glutamate receptor 5 (mGlu5) negative allosteric modulator (NAM) chemotypes. Select acetylenic mGlu5 NAM lead compounds were rationally modified to contain either a benzophenone or an aryl azide as a photoreactive functional group, enabling irreversible covalent attachment to mGlu5 via photoactivation. Additionally, a terminal alkyne or an aliphatic azide was incorporated as a click chemistry handle, allowing chemoselective attachment of fluorescent moieties to the irreversibly mGlu5-bound probe via tandem photoaffinity labeling-bioorthogonal conjugation. These clickable photoprobes retained submicromolar affinity for mGlu5 and negative cooperativity with glutamate, interacted with the "common allosteric-binding site," displayed slow binding kinetics, and could irreversibly label mGlu5 following UV exposure. We depleted the number of functional mGlu5 receptors using an irreversibly bound NAM to elucidate and delineate orthosteric agonist affinity and efficacy. Finally, successful conjugation of fluorescent dyes via click chemistry was demonstrated for each photoprobe. In the future, these clickable photoprobes are expected to aid our understanding of the structural basis of mGlu5 allosteric modulation. Furthermore, tandem photoaffinity labeling-bioorthogonal conjugation is expected to be a broadly applicable experimental strategy across the entire GPCR superfamily.
G蛋白偶联受体(GPCRs)是目前最大的一类药物靶点。特别是,小分子变构调节剂在选择性“调节”GPCR活性方面具有巨大潜力。然而,仍然迫切需要能够明确确定直接变构配体与GPCR相互作用的实验策略,以促进化学生物学研究和基于合理结构的药物设计。我们现在报告基于代谢型谷氨酸受体5(mGlu5)负性变构调节剂(NAM)化学类型开发并使用了用于GPCR的一流可点击变构光探针。对选定的炔基mGlu5 NAM先导化合物进行合理修饰,使其含有二苯甲酮或芳基叠氮化物作为光反应性功能基团,从而能够通过光活化与mGlu5进行不可逆的共价连接。此外,引入末端炔烃或脂肪族叠氮化物作为点击化学手柄,允许通过串联光亲和标记-生物正交共轭将荧光部分化学选择性地连接到与mGlu5不可逆结合的探针上。这些可点击光探针对mGlu5保持亚微摩尔亲和力,并与谷氨酸具有负协同性,与“常见变构结合位点”相互作用,显示出缓慢的结合动力学,并且在紫外线照射后能够不可逆地标记mGlu5。我们使用不可逆结合的NAM耗尽功能性mGlu5受体的数量,以阐明和描述正构激动剂的亲和力和效力。最后,证明了每种光探针通过点击化学成功共轭荧光染料。未来,这些可点击光探针有望帮助我们理解mGlu5变构调节的结构基础。此外,串联光亲和标记-生物正交共轭有望成为整个GPCR超家族广泛适用的实验策略。